Armata Pharmaceuticals, Inc. (ARMP) vs Spruce Biosciences, Inc. (SPRB)

Armata Pharmaceuticals, Inc. and Spruce Biosciences, Inc. are both Biotechnology companies. Armata Pharmaceuticals, Inc. and Spruce Biosciences, Inc. are of similar size ($140.9M and $136.5M). Armata Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −19.3% against −51.3%. Spruce Biosciences, Inc. has the higher net margin (0.00% vs −3,467.0%) and the higher return on invested capital (0.00% vs −89.6%). Across the 15 metrics below, Spruce Biosciences, Inc. leads on 10 and Armata Pharmaceuticals, Inc. on 5.

Valuation

Metric ARMP SPRB Biotechnology median
P/E n/m n/m 7.88
P/S 24.46 24.12 11.47
P/B n/m 1.41 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 71.29 5.95 10.73
Earnings yield (143.90%) (81.65%) (28.84%)
Free cash flow yield (19.02%) (36.12%) (23.03%)

Profitability

Metric ARMP SPRB Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (734.19%) 0.00% 0.00%
Net margin (3,467.04%) 0.00% 0.00%
Free cash flow margin (465.34%) 0.00% 0.00%
Return on equity 127.83% (105.98%) (57.72%)
Return on assets (225.11%) (82.38%) (49.22%)
Return on invested capital (89.61%) 0.00% 0.00%

Growth

Metric ARMP SPRB Biotechnology median
Revenue growth (TTM) (19.29%) (51.32%) 5.64%
EPS growth (last fiscal year) (1,398.60%) 47.59% —
Revenue growth, 5-year CAGR 42.90% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARMP SPRB Biotechnology median
Debt to equity (1.23) 0.08 0.00
Current ratio 0.11 9.23 4.73
Net debt to EBITDA (7.07) 1.34 0.96

Dividend

Metric ARMP SPRB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ARMP SPRB Biotechnology median
Market cap 136.46m 140.88m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack